Understanding the increased susceptibility to asthma development in preterm infants

Preterm birth is associated with aberrant pulmonary development and increased susceptibility to a range of chronic lung diseases. Even in healthy preterms, the prevalence of physician‐diagnosed asthma is far higher than in infants born at term. While physiological, environmental, and genetic factors have been studied extensively, few studies have investigated the immunological factors underpinning this increased susceptibility. Lower rates of atopy and allergic sensitization in preterm compared to term infants suggests non‐allergic mechanisms may be driving asthma development in preterms. Preterm infants are more likely to develop severe RSV and HRV disease and have altered microbiomes compared to term infants. Therefore, investigating the differences in immunological interactions (e.g., response to viral infections, microbiome) between children born preterm and term will aid in understanding the immunological basis for their increased susceptibility to asthma development. This is critical to inform the development of interventions to reduce the burden of asthma in this highly vulnerable demographic.

[1]  J. Sundquist,et al.  Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study , 2022, Thorax.

[2]  P. Licciardi,et al.  Targeted strategies are needed to prevent childhood asthma , 2022, European Respiratory Journal.

[3]  E. Dempsey,et al.  Clinical implications of preterm infant gut microbiome development , 2021, Nature Microbiology.

[4]  E. Castro-Nallar,et al.  Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study , 2021, European Respiratory Journal.

[5]  Shou-Yien Wu,et al.  Vitamin D status in very low birth weight infants and response to vitamin D intake during their NICU stays: a prospective cohort study , 2021, Journal of Perinatology.

[6]  A. Hedman,et al.  Preterm birth reduces the risk of IgE sensitization up to early adulthood: A population‐based birth cohort study , 2021, Allergy.

[7]  F. Martinez,et al.  Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis. , 2021, The Journal of allergy and clinical immunology.

[8]  Marjolein J. W. de Bruijn,et al.  Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  M. Pérez‐Losada,et al.  Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma , 2021, Nature Communications.

[10]  H. Hammad,et al.  The basic immunology of asthma , 2021, Cell.

[11]  R. Geha,et al.  Multi-kingdom ecological drivers of microbiota assembly in preterm infants , 2021, Nature.

[12]  D. Pellicci,et al.  Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity , 2021, Thorax.

[13]  C. Stanton,et al.  Metagenomic analysis of mother-infant gut microbiome reveals global distinct and shared microbial signatures , 2021, Gut microbes.

[14]  R. Hendriks,et al.  Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis , 2020, European Respiratory Review.

[15]  M. L. García-García,et al.  Asthma prevalence, lung and cardiovascular function in adolescents born preterm , 2020, Scientific Reports.

[16]  M. Ege,et al.  Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma , 2020, Nature Medicine.

[17]  M. Shields,et al.  Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review , 2020, Systematic Reviews.

[18]  R. Penn.  Mast cells in asthma: Here I am, stuck in the middle with you , 2020, European Respiratory Journal.

[19]  B. Finlay,et al.  Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies. , 2020, The Lancet. Respiratory medicine.

[20]  M. Sokolowska,et al.  The Role of Lung and Gut Microbiota in the Pathology of Asthma , 2020, Immunity.

[21]  G. O'Connor,et al.  Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. , 2020, The New England journal of medicine.

[22]  O. Ramilo,et al.  Recurrent wheezing during the first 3 years of life in a birth cohort of moderate‐to‐late preterm infants , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[23]  T. Cherian,et al.  Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting , 2020, Vaccine.

[24]  M. Tang,et al.  Postnatal probiotics and allergic disease in very preterm infants: Sub‐study to the ProPrems randomized trial , 2020, Allergy.

[25]  P. Foster,et al.  Neutrophilic asthma: welcome back! , 2019, European Respiratory Journal.

[26]  A. Mannelli,et al.  Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma , 2019, European Respiratory Journal.

[27]  A. Custovic,et al.  Epidemiology of Asthma in Children and Adults , 2019, Front. Pediatr..

[28]  Silvia Castillo-Corullón,et al.  Respiratory morbidity, atopy and asthma at school age in preterm infants aged 32–35 weeks , 2019, European Journal of Pediatrics.

[29]  B. Finlay,et al.  Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review , 2019, The Journal of allergy and clinical immunology.

[30]  N. Marlow,et al.  Airway microbiome in adult survivors of extremely preterm birth: the EPICure study , 2018, European Respiratory Journal.

[31]  J. Ludvigsson,et al.  Cesarean delivery, preterm birth, and risk of food allergy: Nationwide Swedish cohort study of more than 1 million children , 2018, The Journal of allergy and clinical immunology.

[32]  M. Delday,et al.  Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration , 2018, Scientific Reports.

[33]  J. Mikes,et al.  Stereotypic Immune System Development in Newborn Children , 2018, Cell.

[34]  S. Hiles,et al.  Health‐related quality of life burden in severe asthma , 2018, The Medical journal of Australia.

[35]  M. Bizzarro.  Avoiding Unnecessary Antibiotic Exposure in Premature Infants: Understanding When (Not) to Start and When to Stop. , 2018, JAMA network open.

[36]  M. Rovers,et al.  Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[37]  C. Holweg,et al.  Interleukin-13 in Asthma and Other Eosinophilic Disorders , 2017, Front. Med..

[38]  M. Cabana,et al.  Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial , 2017, Pediatrics.

[39]  A. Menzies-Gow,et al.  The Biology of Eosinophils and Their Role in Asthma , 2017, Front. Med..

[40]  E. Simões,et al.  Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six‐Year Follow‐up Study , 2017, American journal of respiratory and critical care medicine.

[41]  M. Sheridan-Pereira,et al.  Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons , 2017, The Pediatric infectious disease journal.

[42]  Jamie Perin,et al.  Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals , 2016, The Lancet.

[43]  J. Schwarze,et al.  Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis , 2016, Thorax.

[44]  W. Carlo,et al.  The Airway Microbiome at Birth , 2016, Scientific Reports.

[45]  A. Levin,et al.  Neonatal gut microbiota associates with childhood multi–sensitized atopy and T–cell differentiation , 2016, Nature Medicine.

[46]  Qingling Zhang,et al.  Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes , 2016, PloS one.

[47]  C. Tomaz,et al.  Alternaria alternata allergens: Markers of exposure, phylogeny and risk of fungi-induced respiratory allergy. , 2016, Environment international.

[48]  Joseph R Arron,et al.  The airway microbiome in patients with severe asthma: Associations with disease features and severity. , 2015, The Journal of allergy and clinical immunology.

[49]  Tobias Kollmann,et al.  Early infancy microbial and metabolic alterations affect risk of childhood asthma , 2015, Science Translational Medicine.

[50]  Richard Beasley,et al.  Risk factors for asthma: is prevention possible? , 2015, The Lancet.

[51]  B. Zuckerman,et al.  Preterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma Definitions. , 2015, American journal of respiratory and critical care medicine.

[52]  K. Helin,et al.  RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo , 2015, PLoS pathogens.

[53]  A. Bush,et al.  Lung consequences in adults born prematurely , 2015, Thorax.

[54]  Geovanny F. Perez,et al.  Rhinovirus‐induced airway cytokines and respiratory morbidity in severely premature children , 2015, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[55]  H. Hammad,et al.  The immunology of asthma , 2014, Nature Immunology.

[56]  A. Magnan,et al.  IL-17 in severe asthma. Where do we stand? , 2014, American journal of respiratory and critical care medicine.

[57]  J. Bird,et al.  The Burden of Childhood Asthma and Late Preterm and Early Term Births , 2014, Pediatrics.

[58]  T. Craig.  Asthma Epidemiology and Risk Factors , 2014 .

[59]  M. Bernardino Neto,et al.  Human Rhinovirus and Disease Severity in Children , 2014, Pediatrics.

[60]  S. Barbarot,et al.  Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age , 2013, The British journal of dermatology.

[61]  E. Simões,et al.  Effect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants , 2013, Pediatrics.

[62]  D. Jarvis,et al.  Staphylococcus aureus enterotoxin‐specific IgE is associated with asthma in the general population: a GA2LEN study , 2013, Allergy.

[63]  I. Aoki,et al.  Pathology of asthma , 2013, Front. Microbiol..

[64]  S. Johnston,et al.  Rhinovirus infection and healthcare utilisation in prematurely born infants , 2013, European Respiratory Journal.

[65]  N. Thomson,et al.  Smoking and asthma: dangerous liaisons , 2012, European Respiratory Journal.

[66]  K. Carlsen,et al.  The significance of early recurrent wheeze for asthma outcomes in late childhood , 2012, European Respiratory Journal.

[67]  S. Turner,et al.  Childhood respiratory cohort studies: do they generate useful outcomes? , 2012, Breathe.

[68]  F. Polack,et al.  Human Rhinoviruses in Severe Respiratory Disease in Very Low Birth Weight Infants , 2012, Pediatrics.

[69]  S. Lorch,et al.  Association of Late-Preterm Birth With Asthma in Young Children: Practice-Based Study , 2011, Pediatrics.

[70]  Carole Ober,et al.  The genetics of asthma and allergic disease: a 21st century perspective , 2011, Immunological reviews.

[71]  J. Sundquist,et al.  Gestational age at birth and risk of allergic rhinitis in young adulthood. , 2011, The Journal of allergy and clinical immunology.

[72]  J. Eriksson,et al.  Preterm birth reduces the incidence of atopy in adulthood. , 2011, The Journal of allergy and clinical immunology.

[73]  Tanja Woyke,et al.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. , 2011, The Journal of allergy and clinical immunology.

[74]  T. Keil,et al.  Allergic rhinitis as a predictor for wheezing onset in school-aged children. , 2010, The Journal of allergy and clinical immunology.

[75]  Wai-ming Lee,et al.  Association between human rhinovirus C and severity of acute asthma in children , 2010, European Respiratory Journal.

[76]  Byoung-Ju Kim,et al.  The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model , 2010, Allergy, asthma & immunology research.

[77]  A. V. van Loon,et al.  HUMAN RHINOVIRUS CAUSES SEVERE INFECTION IN PRETERM INFANTS , 2009, The Pediatric infectious disease journal.

[78]  Xue-Jun Guo,et al.  [The epigenetics in asthma]. , 2009, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[79]  Wai-ming Lee,et al.  Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. , 2008, American journal of respiratory and critical care medicine.

[80]  Marilyn Halonen,et al.  Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study , 2008, The Lancet.

[81]  R. Kurukulaaratchy,et al.  IL13 gene polymorphisms modify the effect of exposure to tobacco smoke on persistent wheeze and asthma in childhood, a longitudinal study , 2008, Respiratory research.

[82]  Hans Bisgaard,et al.  Childhood asthma after bacterial colonization of the airway in neonates. , 2007, The New England journal of medicine.

[83]  E. Simões,et al.  Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. , 2007, The Journal of pediatrics.

[84]  B. Gessner,et al.  Asthma is associated with preterm birth but not with small for gestational age status among a population-based cohort of Medicaid-enrolled children <10 years of age , 2006, Thorax.

[85]  M. Jaakkola,et al.  Preterm delivery and asthma: a systematic review and meta-analysis. , 2006, The Journal of allergy and clinical immunology.

[86]  B. Niggemann,et al.  Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study , 2006, The Lancet.

[87]  M. Järvelin,et al.  Gestational age and occurrence of atopy at age 31—a prospective birth cohort study in Finland , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[88]  Tamekia Jones,et al.  Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis , 2019 .

[89]  D. M.,et al.  Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants. , 2016, The New England journal of medicine.